Mr. Philip Astley-sparke

CHAIRMAN
Business Management
oxyrane
Belgium

Biography

Former President and Chief Executive Officer of BioVex until he sold the company to Amgen in 2011. Prior to Biovex, Mr. Astley-Sparke was an investment banker with Chase/Robert Fleming. Mr. Astley-Sparke is a chartered accountant and holds a BA in Cellular Pathology and Molecular Pathology from Bristol University (UK).

Research Interest

Business development

Global Experts from Belgium

Global Experts in Subject

Share This Profile

Recent Expert Updates

Matthew L Stone
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. Matthew
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. L Stone Matthew
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. L Stone
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. Matthew L Stone
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. R Sameh
pediatrics
King Abdul Aziz University
United Arab Emirates
Dr. R Ismail,
pediatrics
King Abdul Aziz University
United Arab Emirates
Sameh R Ismail,
pediatrics
King Abdul Aziz University
United Arab Emirates
Dr. Sameh R Ismail,
pediatrics
King Abdul Aziz University
United Arab Emirates
Dr. William
pediatrics
Maimonides Medical Center
United States of America